Sonnet BioTherapeutics Holdings, Inc. (SONN)
USD 1.61
(-6.4%)
USD 1.61
(-6.4%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 147.8 Thousand | 349.94 Thousand | 483.62 Thousand | - | 40.61 Million | 30.73 Million |
| Cost of Revenue | 11.81 Million | 93.25 Thousand | 16.63 Million | 58.31 Thousand | 7.93 Million | 29.94 Million |
| Gross Profit | -11.66 Million | 256.68 Thousand | -16.15 Million | -58.31 Thousand | 32.68 Million | 791.1 Thousand |
| Operating Expenses | 7.12 Million | 30.01 Million | 25.57 Million | 17.41 Million | 4.7 Million | 3.86 Million |
| Selling, General and Administrative Expenses | 7.12 Million | 8.57 Million | 8.93 Million | 7.53 Million | 2.5 Million | 3.86 Million |
| Research and Development Expenses | 11.81 Million | 21.44 Million | 16.63 Million | 9.87 Million | 2.19 Million | 154.71 Thousand |
| Other Expenses | - | - | 125.5 Thousand | - | 11.05 Million | 11.05 Million |
| Cost and Expenses | 18.94 Million | 30.01 Million | 25.57 Million | 17.41 Million | 4.7 Million | 33.8 Million |
| Operating Income | -18.79 Million | -29.66 Million | -25.08 Million | -24.23 Million | -4.7 Million | -3.07 Million |
| Interest Expense | - | - | - | 20.67 Thousand | 162.87 Thousand | 381.67 Thousand |
| Income Tax Expense | - | 52.48 Thousand | 22.02 Thousand | 6.79 Million | 162.87 Thousand | -701.22 Thousand |
| Earnings before Tax | -18.83 Million | -29.72 Million | -24.98 Million | -24.26 Million | -4.87 Million | -8.07 Million |
| Net Income | -18.83 Million | -29.77 Million | -25 Million | -31.06 Million | -5.03 Million | -6.85 Million |
| Earnings Per Share Basic | -18.14 | -150.79 | -313.76 | -1015.55 | -5776.45 | -15.59 Thousand |
| Earnings Per Share Diluted | -18.14 | -150.79 | -313.76 | -1015.55 | -5776.45 | -15.59 Thousand |
| Weighted Average Shares Outstanding | 1.03 Million | 197.46 Thousand | 79.69 Thousand | 30.58 Thousand | 871.48 | 439.58 |
| Weighted Average Shares Outstanding (Diluted) | 1.03 Million | 197.46 Thousand | 79.69 Thousand | 30.58 Thousand | 871.48 | 439.58 |
| Gross Margin | -78.93 | 0.73 | -33.40 | - | 0.80 | 0.03 |
| EBIT Margin | -126.63 | -84.63 | -51.63 | - | -0.12 | -0.04 |
| Profit Margin | -127.42 | -85.08 | -51.71 | - | -0.12 | -0.22 |
| EBITDA | -18.71 Million | -29.57 Million | -24.99 Million | -24.23 Million | -13.15 Million | -3.7 Million |
| Earnings Before Tax Margin | -127.14 | -84.78 | -51.87 | - | -0.12 | -0.10 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 18.62 Thousand | 37.25 Thousand | 147.8 Thousand | 36.85 Thousand |
| Cost of Revenue | 21.03 Thousand | 20.49 Thousand | 19.97 Thousand | 19.46 Thousand | 75.75 Thousand | 18.97 Thousand |
| Gross Profit | -21.03 Thousand | -20.49 Thousand | -1348.00 | 17.78 Thousand | 72.05 Thousand | 17.87 Thousand |
| Operating Expenses | 3.5 Million | 3.84 Million | 1.27 Million | 3.63 Million | 18.94 Million | 3.95 Million |
| Selling, General and Administrative Expenses | 1.8 Million | 1.7 Million | 653.45 Thousand | 1.79 Million | - | 1.54 Million |
| Research and Development Expenses | 1.7 Million | 2.14 Million | 624.06 Thousand | 1.84 Million | - | 2.4 Million |
| Other Expenses | -1.72 Million | 4.32 Million | - | - | - | - |
| Cost and Expenses | 3.52 Million | 3.86 Million | 1.29 Million | 3.63 Million | 18.94 Million | 3.95 Million |
| Operating Income | -3.52 Million | -3.86 Million | -1.27 Million | -3.6 Million | -18.79 Million | -3.91 Million |
| Interest Expense | - | - | - | 67.94 Thousand | - | - |
| Income Tax Expense | 1.00 | 4.00 | -4.00 | 76.59 Thousand | 40.07 Thousand | 31.43 Thousand |
| Earnings before Tax | -3.5 Million | 365.42 Thousand | -1.16 Million | -3.67 Million | -18.83 Million | -3.94 Million |
| Net Income | -3.5 Million | 365.42 Thousand | -1.16 Million | -3.67 Million | -18.83 Million | -3.94 Million |
| Earnings Per Share Basic | -0.70 | 0.08 | -0.31 | -2.09 | - | -2.96 |
| Earnings Per Share Diluted | -0.70 | 0.08 | -0.31 | -2.09 | - | -2.96 |
| Weighted Average Shares Outstanding | 5.03 Million | 4.61 Million | 3.79 Million | 1.75 Million | 1.03 Million | 1.33 Million |
| Weighted Average Shares Outstanding (Diluted) | 5.03 Million | 4.61 Million | 3.79 Million | 1.75 Million | 1.03 Million | 1.33 Million |
| Gross Margin | - | - | -0.07 | 0.48 | 0.49 | 0.49 |
| EBIT Margin | - | - | -67.59 | -94.06 | - | -104.88 |
| Profit Margin | - | - | -62.74 | -98.69 | -127.42 | -107.10 |
| EBITDA | -3.5 Million | -3.84 Million | -1.25 Million | -3.5 Million | - | -3.86 Million |
| Earnings Before Tax Margin | - | - | -68.66 | -96.64 | -127.14 | -106.25 |
600523
603680
ITMG
0LFS
6733
GKOS